- Report
- April 2025
- 130 Pages
Global
From €4392EUR$4,900USD£3,823GBP
- Report
- April 2025
- 130 Pages
Global
From €4392EUR$4,900USD£3,823GBP
- Report
- March 2026
- 140 Pages
Global
From €3585EUR$3,999USD£3,120GBP
- Report
- March 2026
- 136 Pages
Global
From €3585EUR$3,999USD£3,120GBP
- Report
- February 2026
- 141 Pages
Global
From €3585EUR$3,999USD£3,120GBP
- Report
- October 2025
- 150 Pages
Global
From €3585EUR$3,999USD£3,120GBP
- Report
- September 2025
- 147 Pages
Global
From €3585EUR$3,999USD£3,120GBP
- Report
- August 2025
- 123 Pages
Global
From €3585EUR$3,999USD£3,120GBP
- Report
- December 2025
- 200 Pages
Global
From €2680EUR$2,990USD£2,333GBP
- Report
- May 2025
- 200 Pages
Global
From €2232EUR$2,490USD£1,943GBP
- Report
- May 2025
- 200 Pages
Global
From €2232EUR$2,490USD£1,943GBP
- Report
- January 2026
- 189 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP
- Report
- January 2026
- 196 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP
- Report
- January 2026
- 190 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP
- Report
- January 2026
- 196 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP
- Report
- January 2026
- 184 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP
- Report
- January 2026
- 181 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP
- Report
- January 2026
- 192 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP
- Report
- January 2026
- 193 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP
- Report
- January 2026
- 199 Pages
Global
From €3178EUR$3,545USD£2,766GBP
€3531EUR$3,939USD£3,073GBP

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments.
The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more